HealthEquity (NASDAQ:HQY) Releases FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 3.570-3.740 for the period, compared to the consensus estimate of 3.760. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

HealthEquity Stock Down 17.1 %

Shares of HQY opened at $84.32 on Thursday. HealthEquity has a one year low of $65.01 and a one year high of $115.59. The company has a market cap of $7.31 billion, a P/E ratio of 77.36, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a 50 day simple moving average of $105.51 and a two-hundred day simple moving average of $95.59.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research analyst reports. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Barrington Research reissued an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. Royal Bank of Canada increased their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Finally, Raymond James boosted their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $112.92.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.20% of the stock is owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.